# Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee

> **NCT02554552** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Yooyoung Pharmaceutical Co., Ltd.**

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** YY1201 2ml
- **DRUG:** Placebo 2ml
- **DRUG:** YY1201 3ml
- **DRUG:** Placebo 3ml

## Key facts

- **NCT ID:** NCT02554552
- **Lead sponsor:** Yooyoung Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-09
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This study has been withdrawn prior to enrollment.
- **Last updated:** 2016-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02554552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02554552, "Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02554552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*